Business
Why the Mesoblast (ASX:MSB) share price is sinking 11% lower – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is sinking lower on Tuesday. Here’s what you need to know…
The Mesoblast limited(ASX: MSB) share price has come under pressure on Tuesday after the release of an announcement.
At the time of writing the allogeneic cellular medicines developer’s shares are down 11% to $4.03.
What did Mesoblast announce?
This morning Mesoblast announced the top-line results from the landmark DREAM-HF Phase 3 randomised controlled trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR) in 537 patients with advanced chronic heart failure.
According to the release,…
-
Noosa News22 hours agoFila Casablanca – Concrete Playground
-
Noosa News15 hours agoBrisbane on top as American, Asian tourists flock to city
-
General20 hours agoDebt forecast has alarm bells ringing for Olympic hosts
-
General17 hours agoAustralia’s mental health plan ‘not fit for purpose’ and must be re-designed, new report finds